Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study

被引：0
作者：
M. Carron
G. Andreatta
E. Pesenti
A. De Cassai
P. Feltracco
F. Linassi
M. Sergi
C. Di Bella
M. Di Bello
F. Neri
C. Silvestre
L. Furian
P. Navalesi
机构：
[1] University of Padova,Department of Medicine, DIMED, Section of Anesthesiology and Intensive Care
[2] Azienda Ospedale Università Padova,Institute of Anesthesia and Intensive Care
[3] Ca’ Foncello Treviso Regional Hospital,Department of Anesthesia and Intensive Care
[4] University of Padova,Department of Surgical, Oncological and Gastroenterological Sciences, Kidney and Pancreas Transplantation Unit
[5] Azienda Ospedale Università Padova,Kidney and Pancreas Transplantation Unit
来源：
Perioperative Medicine | / 11卷
关键词：
Anesthesia; Neuromuscular block; Rocuronium; Cisatracurium; Sugammadex; Neostigmine; End-stage renal disease; Kidney transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 1111 条
[1]  
Adams DR(2020)Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study Anaesthesia 75 348-352
[2]  
Tollinche LE(2019)Retrospective investigation of grafted kidney function after reversal of neuromuscular blockade using neostigmine or sugammadex Transplant Proc 51 2265-2267
[3]  
Yeoh CB(2020)Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data Br J Anaesth 124 63-72
[4]  
Artman J(2009)Preclinical pharmacology of sugammadex J Crit Care 24 29-35
[5]  
Mehta M(2011)Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys Ren Fail 33 1019-1024
[6]  
Phillips D(2017)Current status of neuromuscular reversal and monitoring: challenges and opportunities Anesthesiology 126 173-190
[7]  
Fischer GW(2018)Comparison of the cytotoxic, genotoxic and apoptotic effects of sugammadex and neostigmine on human embryonic renal cell (HEK-293) Cell Mol Biol (Noisy-le-grand) 64 74-78
[8]  
Quinlan JJ(2012)Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment Br J Anaesth 109 382-390
[9]  
Sakai T(2016)Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center Clinicoecon Outcomes Res 8 43-45
[10]  
Arslantas R(2020)Role of sugammadex in accelerating postoperative discharge: an updated meta-analysis J Clin Anesth 65 109895-12
12345678910